3 documents found, page 1 of 1
Tixagevimab-cilgavimab (AZD7442) for the treatment of patients hospitalized wit...
Hites, M; Lapique, EL; Massonnaud, CR; Belhadi, D; Jamard, S; Goehringer, F; Danion, F; Reignier, J; de Castro, N; Garot, D; Lacombe, K; Tolsma, V
The Association Between Hepatitis B Virus Infection and Nonliver Malignancies i...
Mocroft, A; Miro, J; Wandeler, G; Llibre, J; Boyd, A; van Bremen, K; Beniowski, M; Mikhalik, J; Cavassini, M; Maltez, F; Duvivier, C; Uberti Foppa, CObjectives: The aim of this study was to assess the impact of hepatitis B virus (HBV) infection on non-liver malignancies in people living with HIV (PLWH). Methods: All persons aged ≥ 18 years with known hepatitis B virus (HBV) surface antigen (HBsAg) status after the latest of 1 January 2001 and enrolment in the EuroSIDA cohort (baseline) were included in the study; persons were categorized as HBV positive or ...
Antiretrovirals, Fractures, and Osteonecrosis in a Large International HIV Cohort
Borges, A; Hoy, J; Florence, E; Sedlacek, D; Stellbrink, HJ; Uzdaviniene, V; Tomazic, J; Gargalianos-Kakolyris, P; Schmid, P; Orkin, C; Pedersen, CBackground: Antiretrovirals (ARVs) affect bone density and turnover, but their effect on risk of fractures and osteonecrosis of the femoral head is less understood. We investigated if exposure to ARVs increases the risk of both bone outcomes. Methods: EuroSIDA participants were followed to assess fractures and osteonecrosis. Poisson regression identified clinical, laboratory and demographic predictors of either...